| Literature DB >> 35265417 |
Tatsuaki Ishiguro1, Ryumei H Ishiguro1, Miyu Ishiguro1, Atsushi Toki2, Hiroshi Terunuma3.
Abstract
We formerly reported that the combination of dichloroacetate, omeprazole, and tamoxifen blocked cancer progression by reducing lactic acid production and inducing superoxide production. Recently, ivermectin, a well-known anti-parasite drug, was reported to share the same mechanisms with them and have anti-tumor activity. Here, we present three patients in whom the combination of dichloroacetate, omeprazole (plus tamoxifen), and ivermectin dramatically relieved the symptoms accompanying cancer and sarcoma progression.Entities:
Keywords: cancer; dichloroacetate; ivermectin; omeprazole; sarcoma; tamoxifen
Year: 2022 PMID: 35265417 PMCID: PMC8898092 DOI: 10.7759/cureus.21884
Source DB: PubMed Journal: Cureus ISSN: 2168-8184